Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 6
Submit an article Journal homepage
149
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

A Case Report of Conjunctival Extranodal Marginal Zone Lymphoma Treated with Intralesional Rituximab Injection Therapy

Titap Yazicioglua Department of Ophthalmology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, TurkeyView further author information
,
Murat Oklara Department of Ophthalmology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, TurkeyCorrespondence[email protected]
View further author information
,
Seyhan Kocabasb Department of Ophthalmology, Dünyagöz Hospital, Adana, TurkeyView further author information
,
Erdi Karadaga Department of Ophthalmology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, TurkeyView further author information
,
Vildan Elibolc Department of Pathology, Cengiz Gökçek Gynecology and Pediatrics Hospital, Gaziantep, TurkeyView further author information
&
Mehmet Engin Tezcana Department of Ophthalmology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-1753-4936View further author information
ORCID Icon
Pages 1329-1333 | Received 31 Jan 2022, Accepted 26 Aug 2022, Published online: 09 Sep 2022

References

  • Fisher SG, Fisher RI. The epidemiology of non-Hodgkin’s lymphoma. Oncogene. 2004;23(38):6524–6534. doi:10.1038/sj.onc.1207843.
  • Moslehi R, Devesa SS, Schairer C, et al. Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J Natl Cancer Inst. 2006;98(13):936–939. doi:10.1093/jnci/djj248.
  • Kirkegaard MM, Rasmussen PK, Coupland SE, et al. Conjunctival lymphoma—an international multicenter retrospective study. JAMA Ophthalmol. 2016;134(4):406–414. doi:10.1001/jamaophthalmol.2015.6122.
  • Shome D, Esmaeli B. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa. Curr Opin Ophthalmol. 2008;19(5):414–421. doi:10.1097/ICU.0b013e32830b1539.
  • Graue GF, Finger PT, Maher E, et al. Ocular adnexal lymphoma staging and treatment: American joint committee on cancer versus Ann Arbor. Eur J Ophthalmol. 2013;23(3):344–355. doi:10.5301/ejo.5000224.
  • Kirkegaard MM, Coupland SE, Prause JU, et al. Malignant lymphoma of the conjunctiva. Surv Ophthalmol. 2015;60(5):444–458. doi:10.1016/j.survophthal.2015.05.001.
  • Villa SR, Rodríguez MR, Pabón MV. Intralesional rituximab in primary conjunctival follicular lymphoma relapsed. Archivos de la Sociedad Española de Oftalmología ( English Edition). 2017;92(7):326–329. doi:10.1016/j.oftal.2016.11.004.
  • Ferreri AJ, Govi S, Colucci A, et al. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas. Ophthalmology. 2011;118(1):24–28. doi:10.1016/j.ophtha.2010.04.036.
  • Baldini L, Blini M, Guffanti A, et al. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol. 1998;9(7):779–781. doi:10.1023/A:1008327301372.
  • Harada K, Murakami N, Kitaguchi M, et al. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phy. 2014;88(3):650–654. doi:10.1016/j.ijrobp.2013.11.235.
  • Goda JS, Le LW, Lapperriere NJ, et al. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phy. 2011;81(4):e659–e666. doi:10.1016/j.ijrobp.2011.03.050.
  • Cvetković RS, Perry CM. Rituximab. Drugs. 2006;66(6):791–820. doi:10.2165/00003495-200666060-00005.
  • Tuncer S, Tanyıldız B, Basaran M, et al. Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma: single institution experience. Curr Eye Res. 2015;40(8):780–785. doi:10.3109/02713683.2014.959605.
  • Kimby E. Tolerability and safety of rituximab (MabThera®). Cancer Treat Rev. 2005;31(6):456–473. doi:10.1016/j.ctrv.2005.05.007.
  • Good LM, Miller MD, High WA. Intralesional agents in the management of cutaneous malignancy: a review. J Am Acad Dermatol. 2011;64(2):413–422. doi:10.1016/j.jaad.2009.12.013.
  • Savino G, Battendieri R, Gari M, et al. Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections. J Cancer Res Clin Oncol. 2013;139(7):1251–1255. doi:10.1007/s00432-013-1438-9.
  • Ferreri AJ, Sassone M, Miserocchi E, et al. Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. Blood Adv. 2020;4(6):1013–1019. doi:10.1182/bloodadvances.2020001459.
  • Demirci H, Ozgonul C, Diniz Grisolia AB, et al. Intralesional rituximab injection for low-grade conjunctival lymphoma management. Ophthalmology. 2020;127(9):1270–1273. doi:10.1016/j.ophtha.2020.03.014.
  • Yang JP, Pang X, Zhang K, et al. The preliminary observation of intralesional rituximab administration in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma. Chin J Ophthalmol [ Zhonghua yan ke za Zhi]. 2020;56(11):839–845. doi:10.3760/cma.j.cn112142-20200215-00067.
  • Villa SR, Rodríguez MR, Pabón MV. Rituximab intralesional como tratamiento de linfoma folicular primario de conjuntiva recidivante. Archivos Soc Esp Oftalmología. 2017;92:326–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.